AtriCure Inc (NAS:ATRC)
$ 23.76 2.565 (12.1%) Market Cap: 1.15 Bil Enterprise Value: 1.12 Bil PE Ratio: 0 PB Ratio: 2.52 GF Score: 66/100

AtriCure Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 03:30PM GMT
Release Date Price: $43.9 (-3.98%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. Welcome to the 2023 JPMorgan Conference. I'm Robbie Marcus, the med tech analyst here. I'm very happy to kick off the conference with our first session, AtriCure. And I'll be calling up CEO, Mike Carrel for the presentation. And after about 20 minutes or so, we'll shift over to some Q&A. Mike?

Michael H. Carrel
AtriCure, Inc. - CEO, President & Director

Thanks, Robbie. Thank you, JPMorgan, for having us here today. It's kind of fun to be one of the first people to actually kick off the meeting and then the second year in a row to do it. I think when you're at JPMorgan, you're going to get the sense, and I'm going to go through and come hit on, you're going to see a lot of amazing companies and JPMorgan is basically here to create and show and emphasize all the great technologies that are going on out in the world.

What you'll also hear I think a lot of is looking at the markets, one of the biggest markets that everybody is talking about is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot